PFS No Surrogate for OS in Metastatic Breast Cancer Trials

PFS No Surrogate for OS in Metastatic Breast Cancer Trials

Breast cancer trialists have debated using progression-free survival as a surrogate for overall survival in randomized controlled trials (RCTs). The current study explores this important question for a subset of patients—those with metastatic HER2

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.